104

Selected Document Category:	Published Document
Source:	Nanotechnology Characterization Laboratory
Anticipated Publication Year:
Publication Year:	2011
Acronym:	NCL
Identifier:	STE-3
Document Title:	Detection of Mycoplasma
url:	http://ncl.cancer.gov/NCL_Method_STE-3.pdf
Scope:	Nanoparticles submitted to the NCL may be subjected to testing for mycoplasma when deemed necessary. Mycoplasma is a form of bacteria that lacks a nucleus and a cell wall, and are thus unaffected by many antibiotics. The types of nanoparticle formulations generally tested for mycoplasma contamination include those that in corporate a component derived from a bacterial culture, animal or hybridoma.
Keywords:	hybridoma, mycoplasma
Type of Document:	e. Specification
Issues Areas:	Measurement and Characterizations Health, Safety, and Environment
Primary Category:	Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals
Additional Categories
Goal or Need:
Intended Stakeholders:
Is it Being Implemented:
Submitter's Name:	Admin
Submitter's e-mail:	[email protected]
Submitter's Company:	ANSI
Additional Comments:
Contact for Additional Info:	http://ncl.cancer.gov/working_assay-cascade_download.asp

::::